Skip to main content
ATNM logo
ATNM
(NYSEAMERICAN)
Actinium Pharmaceuticals, Inc.
$0.98-- (--)
Loading... - Market loading

Actinium Pharmaceuticals (ATNM) Stock Price & Financial Analysis

Actinium Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.98 - $1.01
52-Week High$1.95
52-Week Low$0.95
Open$0.99
Volume59.30K
Average Volume (3M)59.30K
Market Cap30.58M
Shares Outstanding31.20M
Price to Sales (P/S)343.15
Price to Book (P/B)2.24
EV/EBITDA0.59
Revenue (TTM)90.00K
Net Income (TTM)-34.60M
EPS (TTM)$-1.11
Profit Margin-38443.33%
Operating Margin-41486.67%
Return on Equity (ROE)-251.01%
Debt to Equity0.08
50-Day MA$1.14
200-Day MA$1.43
52-Week Change-33.56%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Actinium Pharmaceuticals

What is the current stock price for ATNM?

As of the latest trading session, ATNM stock trades at $0.98. The 52-week range is $0.95–$1.95, with a day range of $0.98–$1.01.

What is the P/E ratio for ATNM?

The P/E ratio (Price-to-Earnings) for ATNM is shown in the Key Statistics section. This valuation metric helps compare Actinium Pharmaceuticals, Inc. to industry peers.

Does ATNM pay dividends?

Actinium Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ATNM?

Based on 1 analyst, the consensus for ATNM is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ATNM?

Actinium Pharmaceuticals's market capitalization is $30.6M, classifying it as a micro-cap company. Actinium Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.